Palmitoyl-DL-carnitine chloride
SIGMA/P4509 - powder
Synonym: DL-
CAS Number: 6865-14-1
Empirical Formula (Hill Notation): C23H46ClNO4
Molecular Weight: 436.07
MDL Number: MFCD00063481
Linear Formula: C23H46NO4 · Cl
Product Type: Chemical
| assay | ≥98% (TLC) |
| biological source | synthetic (organic) |
| color | white |
| form | powder |
| InChI | 1S/C23H46NO4.ClH/c1-5-6-7 |
| InChI key | LGVBWSFTXDIBPB-UHFFFAOYSA |
| Quality Level | 200 ![]() |
| SMILES string | Cl.CCCCCCCCCCCCCCCC(=O)OC |
| solubility | H2O: 25 mg/mL (with heat or sonication) |
| storage temp. | −20°C |
| Application: | Palmitoyl-DL-carnitine chloride has been used to study its effect on inflammatory cytokines and calcium (Ca2+) influx, using in vitro models of prostate cancer. |
| Biochem/physiol Actions: | Long-chain acylcarnitine and well-known intermediate in mitochondrial fatty acid oxidation. Modifies myocardial levels of high-energy phosphates and free fatty acids in the heart. Increases erythroid colony formation in culture. Reduces surface negative charge of erythrocytes and myocytes. Reported to affect currents and inhibit endothelium-dependent relaxation induced by acetylcholine and substance P in a dose dependent manner by suppressing the intracellular calcium signal transduction in endothelial cells. |
| Biochem/physiol Actions: | Palmitoyl-DL-carnitine chloride is known to inhibit biofilm formation mediated by Pseudomonas aeruginosa and Escherichia coli. It is a phosphokinase C inhibitor. |
| Packaging: | 1 g in poly bottle |
| Packaging: | 100 mg in poly bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (TLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |

